Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mairedan Muhetarijiang

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Aging and Disease|May 13, 2024
Mitochondrial Dysfunction: A Roadmap for Understanding and Tackling Cardiovascular AgingHan Zhang, Mairedan Muhetarijiang, Ryan J Chen, et al.
Reviews in Cardiovascular Medicine|March 6, 2026
Unraveling Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicities: Pathway Insights, Mechanisms, and Emerging Therapeutic TargetsBiqi Zhang, Mairedan Muhetarijiang, Xiangjie Sun, et al.
British Journal of Cancer|April 6, 2026
Arachidonate lipoxygenase 5 metabolism axis promoting ferroptosis: a potential druggable target for doxorubicin-induced cardiomyopathyLu Chen, Xingang Sun, Han Zhang, et al.
Cancer Immunology, Immunotherapy : CII|October 9, 2025
A pan-cancer single-cell analysis reveals the effect of PD-1 blockades on tumor angiogenesis by inhibiting the endothelial CXCL12-CXCR4 axisMairedan Muhetarijiang, Pengwei Zhu, Han Zhang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Aging and Disease|May 13, 2024
Mitochondrial Dysfunction: A Roadmap for Understanding and Tackling Cardiovascular AgingHan Zhang, Mairedan Muhetarijiang, Ryan J Chen, et al.
Reviews in Cardiovascular Medicine|March 6, 2026
Unraveling Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicities: Pathway Insights, Mechanisms, and Emerging Therapeutic TargetsBiqi Zhang, Mairedan Muhetarijiang, Xiangjie Sun, et al.
British Journal of Cancer|April 6, 2026
Arachidonate lipoxygenase 5 metabolism axis promoting ferroptosis: a potential druggable target for doxorubicin-induced cardiomyopathyLu Chen, Xingang Sun, Han Zhang, et al.
Cancer Immunology, Immunotherapy : CII|October 9, 2025
A pan-cancer single-cell analysis reveals the effect of PD-1 blockades on tumor angiogenesis by inhibiting the endothelial CXCL12-CXCR4 axisMairedan Muhetarijiang, Pengwei Zhu, Han Zhang, et al.
Pageof 1